Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Marinus Pharmaceuticals
Pharma
Marinus seizure med fails at interim analysis; shares plummet
After disappointing interim trial results for its IV seizure med, Marinus' stock has tumbled and the company is weighing "cost-saving strategies."
Kevin Dunleavy
Apr 15, 2024 12:31pm
HHS taps Marinus Pharma to produce API for anti-seizure drug
Sep 22, 2022 9:40am
Marinus starts marketing voyage for kids epilepsy med Ztalmy
Aug 2, 2022 9:50am
Marinus restarts phase 3 seizure trials after supply delays
May 5, 2022 10:20am
Once on the scrapheap, Marinus' seizure drug wins FDA approval
Mar 18, 2022 6:48pm
Novartis, BMS, Innovent, Lilly, Akebia await FDA decisions
Mar 2, 2022 10:10am